Skip to Content
Søk Menu

Abstract: Den första IL-17A/F-nanokroppen på gång mot plackpsoriasis

Få tillgång

Om du är läkare, sjuksköterska eller annan vårdpersonal kan du komma åt hela artikeln genom att skapa en profil på BestPractice Nordic.

Relaterat innehåll

Lone Skov

EADV 2024 – Still Unanswered Questions about Psoriasis and Psoriasis Treatment

/ Lone Skov
EADV24PsoriasisPsoriasisartrit Play the Video 05:10

Deucravacitinib, A New Oral Option for Patients with Moderate to Severe Psoriasis

/ Sofie Pohl
Psoriasis
Andrew Blauvelt

LBA: Probably the Best in Class for Treatment of Plaque Psoriasis

/ Andrew Blauvelt
EADV24Psoriasis Play the Video 04:38
Christopher Willy Schwarz

Non-Medical Switches of Biosimilar in Psoriasis Treatment Appears Safe

/ Christopher Willy Schwarz
EADV24Psoriasis Play the Video 2:45
Melinda J Gooderham

Key Findings on Deucravacitinib – A New Oral Treatment for Psoriasis

/ Melinda J. Gooderham
EADV24Psoriasis Play the Video 02:51

EADV24: New Research Confirms Link Between Stress and Psoriasis Relapse

/ Sofie Pohl
EADV24Psoriasis
Prof. Matthias Augustin

The WHO-5 Questionnaire: Investigating the Well-Being Psoriasis Patients

/ Matthias Augustin
Psoriasis Play the Video 6:39

Significant Improvement of Quality-of-Life in Patients with Psoriasis

/ Matthias Augustin
Psoriasis Play the Video 05:30

Evaluating patient wellbeing following tildrakizumab treatment: the POSITIVE study

/ Almirall
Psoriasis
Back to top